Share Price and Basic Stock Data
Last Updated: December 6, 2025, 10:34 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Advance Petrochemicals Ltd operates in the inorganic chemicals sector, focusing on the production of various petrochemical products. The company has shown a commendable trajectory in revenue growth, with sales rising from ₹27.92 Cr in FY 2022 to ₹37.09 Cr in FY 2023. This upward trend in sales is a positive signal, reflecting the company’s ability to capture market demand effectively. However, the most recent financials show a slight dip in FY 2024, with revenues declining to ₹35.19 Cr. The trailing twelve months (TTM) figure, reported at ₹48.64 Cr, indicates a recovery as the company seems to regroup. Quarter-on-quarter sales have fluctuated, with a notable increase in the last quarter of FY 2025, where it reached ₹15.16 Cr, suggesting a potential rebound in performance. This volatility could be attributed to the cyclical nature of the chemical industry, influenced by raw material costs and demand fluctuations.
Profitability and Efficiency Metrics
Profitability remains a central concern for Advance Petrochemicals. The company’s operating profit margin (OPM) stood at a modest 3.85% in FY 2025, a decline from 7.44% in FY 2023. This downward trend suggests that while revenue has been growing, costs are also rising, squeezing margins. The net profit margin has hovered around 0.60%, indicating that the company is operating on thin profitability. Moreover, the return on equity (ROE) for FY 2025 was reported at 7.48%, which is relatively low for the chemicals sector, where peers often achieve much higher returns. The cash conversion cycle, recorded at 37.41 days, appears efficient, particularly in a capital-intensive industry, but the high P/E ratio of 472 raises concerns about the stock’s valuation against its earnings potential. As such, the company must focus on improving operational efficiencies to enhance profitability.
Balance Sheet Strength and Financial Ratios
Advance Petrochemicals’ balance sheet reflects a mix of strengths and vulnerabilities. The equity capital has remained stable at ₹0.90 Cr over the years, but borrowings have surged to ₹10.85 Cr, leading to a total debt-to-equity ratio of 2.69 in FY 2025. This level of debt suggests a reliance on external financing, which could pose risks if cash flows do not improve significantly. On a brighter note, the interest coverage ratio of 2.26x indicates that the company generates enough earnings to cover its interest expenses, albeit comfortably. The book value per share has increased to ₹44.86, suggesting that shareholders’ equity is growing, which is a positive sign. However, the high price-to-book value ratio of 4.43x indicates that the market may be pricing in future growth, which could be risky if the company fails to deliver on profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Advance Petrochemicals reveals a stable environment for investor confidence. Promoters hold 50.11% of the shares, a slight increase from earlier periods, suggesting a commitment to the company’s long-term vision. The public shareholding stands at 49.89%, with the total number of shareholders increasing to 2,145. This growth in the shareholder base indicates increasing interest from the retail segment, which can be a positive indicator for future stock performance. However, the absence of foreign institutional investment (FIIs) and domestic institutional investment (DIIs) may be a red flag, as institutional investors typically provide stability and confidence in a stock. This lack of institutional backing could lead to increased volatility in the stock price as market sentiment shifts.
Outlook, Risks, and Final Insight
Looking ahead, Advance Petrochemicals faces a dual-edged sword of opportunity and risk. On one hand, the recovery in sales and the potential for improved operational efficiencies could lead to better profitability. However, the company’s high debt levels and low margins represent significant risks that could impact future performance. Investors should be cautious, as the high P/E ratio may indicate that the stock is overvalued relative to its earnings. Additionally, the chemicals sector is subject to fluctuations in raw material costs and regulatory changes, which could affect margins further. In light of these factors, investors might consider a balanced approach, weighing the potential for growth against the inherent risks. Keeping a close eye on operational performance and market conditions will be crucial for making informed investment decisions in this stock.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Advance Petrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,897 Cr. | 44.8 | 125/40.8 | 144 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.9 Cr. | 29.9 | 47.2/25.8 | 64.9 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 203 Cr. | 260 | 410/238 | 12.1 | 211 | 3.08 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,207 Cr. | 499 | 728/408 | 30.3 | 157 | 0.60 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 324 Cr. | 415 | 536/376 | 15.8 | 144 | 0.72 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,605.25 Cr | 541.43 | 171.15 | 160.00 | 0.51% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.83 | 9.28 | 10.01 | 7.97 | 8.21 | 8.19 | 7.80 | 10.99 | 10.80 | 11.25 | 12.72 | 15.16 | 9.51 |
| Expenses | 8.94 | 8.23 | 9.34 | 7.82 | 8.13 | 7.40 | 7.45 | 10.38 | 10.41 | 11.15 | 12.35 | 14.51 | 9.09 |
| Operating Profit | 0.89 | 1.05 | 0.67 | 0.15 | 0.08 | 0.79 | 0.35 | 0.61 | 0.39 | 0.10 | 0.37 | 0.65 | 0.42 |
| OPM % | 9.05% | 11.31% | 6.69% | 1.88% | 0.97% | 9.65% | 4.49% | 5.55% | 3.61% | 0.89% | 2.91% | 4.29% | 4.42% |
| Other Income | 0.00 | 0.07 | 0.05 | -0.03 | 0.01 | 0.00 | 0.01 | 0.03 | 0.02 | 0.34 | 0.01 | 0.04 | 0.02 |
| Interest | 0.19 | 0.19 | 0.18 | 0.18 | 0.20 | 0.21 | 0.21 | 0.23 | 0.22 | 0.25 | 0.20 | 0.18 | 0.27 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.43 | 0.20 | 0.20 | 0.20 | 0.10 | 0.17 | 0.17 | 0.17 | 0.08 | 0.15 |
| Profit before tax | 0.58 | 0.81 | 0.42 | -0.49 | -0.31 | 0.38 | -0.05 | 0.31 | 0.02 | 0.02 | 0.01 | 0.43 | 0.02 |
| Tax % | 0.00% | 43.21% | 23.81% | -16.33% | 0.00% | 5.26% | 0.00% | 25.81% | 0.00% | 0.00% | 100.00% | 39.53% | 0.00% |
| Net Profit | 0.58 | 0.46 | 0.31 | -0.41 | -0.31 | 0.37 | -0.05 | 0.23 | 0.01 | 0.02 | 0.00 | 0.27 | 0.01 |
| EPS in Rs | 6.44 | 5.11 | 3.44 | -4.56 | -3.44 | 4.11 | -0.56 | 2.56 | 0.11 | 0.22 | 0.00 | 3.00 | 0.11 |
Last Updated: August 20, 2025, 12:25 am
Below is a detailed analysis of the quarterly data for Advance Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9.51 Cr.. The value appears to be declining and may need further review. It has decreased from 15.16 Cr. (Mar 2025) to 9.51 Cr., marking a decrease of 5.65 Cr..
- For Expenses, as of Jun 2025, the value is 9.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.51 Cr. (Mar 2025) to 9.09 Cr., marking a decrease of 5.42 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.42 Cr.. The value appears to be declining and may need further review. It has decreased from 0.65 Cr. (Mar 2025) to 0.42 Cr., marking a decrease of 0.23 Cr..
- For OPM %, as of Jun 2025, the value is 4.42%. The value appears strong and on an upward trend. It has increased from 4.29% (Mar 2025) to 4.42%, marking an increase of 0.13%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.02 Cr..
- For Interest, as of Jun 2025, the value is 0.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.18 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.07 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 39.53% (Mar 2025) to 0.00%, marking a decrease of 39.53%.
- For Net Profit, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.27 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.11. The value appears to be declining and may need further review. It has decreased from 3.00 (Mar 2025) to 0.11, marking a decrease of 2.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.54 | 11.20 | 10.46 | 8.85 | 12.74 | 21.29 | 13.90 | 17.44 | 27.92 | 37.09 | 35.19 | 49.94 | 48.64 |
| Expenses | 12.00 | 10.42 | 9.62 | 7.97 | 11.90 | 20.31 | 12.99 | 16.25 | 26.42 | 34.33 | 33.36 | 48.43 | 47.10 |
| Operating Profit | 0.54 | 0.78 | 0.84 | 0.88 | 0.84 | 0.98 | 0.91 | 1.19 | 1.50 | 2.76 | 1.83 | 1.51 | 1.54 |
| OPM % | 4.31% | 6.96% | 8.03% | 9.94% | 6.59% | 4.60% | 6.55% | 6.82% | 5.37% | 7.44% | 5.20% | 3.02% | 3.17% |
| Other Income | 0.18 | 0.01 | 0.03 | 0.03 | 0.08 | 0.09 | 0.10 | 0.12 | 0.06 | 0.09 | 0.06 | 0.41 | 0.41 |
| Interest | 0.40 | 0.45 | 0.53 | 0.58 | 0.64 | 0.77 | 0.77 | 0.72 | 0.72 | 0.74 | 0.88 | 0.85 | 0.90 |
| Depreciation | 0.13 | 0.20 | 0.19 | 0.18 | 0.18 | 0.19 | 0.17 | 0.22 | 0.40 | 0.79 | 0.70 | 0.60 | 0.57 |
| Profit before tax | 0.19 | 0.14 | 0.15 | 0.15 | 0.10 | 0.11 | 0.07 | 0.37 | 0.44 | 1.32 | 0.31 | 0.47 | 0.48 |
| Tax % | 36.84% | 64.29% | 53.33% | 46.67% | 10.00% | 0.00% | 0.00% | 27.03% | 31.82% | 28.03% | 32.26% | 36.17% | |
| Net Profit | 0.12 | 0.06 | 0.07 | 0.09 | 0.08 | 0.11 | 0.07 | 0.28 | 0.30 | 0.94 | 0.22 | 0.30 | 0.30 |
| EPS in Rs | 1.33 | 0.67 | 0.78 | 1.00 | 0.89 | 1.22 | 0.78 | 3.11 | 3.33 | 10.44 | 2.44 | 3.33 | 3.33 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 16.67% | 28.57% | -11.11% | 37.50% | -36.36% | 300.00% | 7.14% | 213.33% | -76.60% | 36.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 66.67% | 11.90% | -39.68% | 48.61% | -73.86% | 336.36% | -292.86% | 206.19% | -289.93% | 112.96% |
Advance Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 34% |
| 3 Years: | -4% |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 27% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:06 pm
Balance Sheet
Last Updated: December 10, 2025, 3:45 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
| Reserves | 0.63 | 0.68 | 0.75 | 0.84 | 0.92 | 1.03 | 1.10 | 1.38 | 1.67 | 2.62 | 2.84 | 3.14 | 2.91 |
| Borrowings | 3.40 | 4.34 | 5.24 | 5.01 | 6.27 | 6.38 | 6.63 | 7.36 | 6.98 | 7.18 | 8.98 | 10.85 | 12.72 |
| Other Liabilities | 2.07 | 2.17 | 1.51 | 1.84 | 2.61 | 3.25 | 2.08 | 3.14 | 5.89 | 5.02 | 9.94 | 10.45 | 6.34 |
| Total Liabilities | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
| Fixed Assets | 1.57 | 1.82 | 1.91 | 1.79 | 2.06 | 1.81 | 1.65 | 2.65 | 3.45 | 5.00 | 5.76 | 5.17 | 4.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.48 | 0.00 | 0.00 | 0.43 | 0.00 | 2.49 | 3.42 |
| Investments | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.00 |
| Other Assets | 5.07 | 5.91 | 6.13 | 6.19 | 8.28 | 9.39 | 8.22 | 9.77 | 11.63 | 9.93 | 16.54 | 17.32 | 14.57 |
| Total Assets | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
Below is a detailed analysis of the balance sheet data for Advance Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 0.90 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.90 Cr..
- For Reserves, as of Sep 2025, the value is 2.91 Cr.. The value appears to be declining and may need further review. It has decreased from 3.14 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.23 Cr..
- For Borrowings, as of Sep 2025, the value is 12.72 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 10.85 Cr. (Mar 2025) to 12.72 Cr., marking an increase of 1.87 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6.34 Cr.. The value appears to be improving (decreasing). It has decreased from 10.45 Cr. (Mar 2025) to 6.34 Cr., marking a decrease of 4.11 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22.87 Cr.. The value appears to be improving (decreasing). It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4.88 Cr.. The value appears to be declining and may need further review. It has decreased from 5.17 Cr. (Mar 2025) to 4.88 Cr., marking a decrease of 0.29 Cr..
- For CWIP, as of Sep 2025, the value is 3.42 Cr.. The value appears strong and on an upward trend. It has increased from 2.49 Cr. (Mar 2025) to 3.42 Cr., marking an increase of 0.93 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.36 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.36 Cr..
- For Other Assets, as of Sep 2025, the value is 14.57 Cr.. The value appears to be declining and may need further review. It has decreased from 17.32 Cr. (Mar 2025) to 14.57 Cr., marking a decrease of 2.75 Cr..
- For Total Assets, as of Sep 2025, the value is 22.87 Cr.. The value appears to be declining and may need further review. It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
However, the Borrowings (12.72 Cr.) are higher than the Reserves (2.91 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.86 | -3.56 | -4.40 | -4.13 | -5.43 | -5.40 | -5.72 | -6.17 | -5.48 | -4.42 | -7.15 | -9.34 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61.71 | 73.98 | 80.26 | 51.97 | 53.00 | 41.83 | 32.30 | 53.16 | 63.93 | 35.92 | 93.56 | 70.97 |
| Inventory Days | 77.37 | 118.64 | 135.92 | 271.87 | 226.41 | 127.25 | 217.07 | 185.97 | 111.70 | 76.07 | 89.34 | 53.73 |
| Days Payable | 38.87 | 49.55 | 34.11 | 98.61 | 89.06 | 61.39 | 56.50 | 75.02 | 100.40 | 57.52 | 131.91 | 87.28 |
| Cash Conversion Cycle | 100.21 | 143.07 | 182.07 | 225.22 | 190.35 | 107.69 | 192.87 | 164.11 | 75.23 | 54.46 | 50.98 | 37.41 |
| Working Capital Days | 25.32 | 22.81 | 20.24 | 29.69 | 25.78 | 11.66 | 13.39 | 13.19 | 3.53 | -5.90 | 0.93 | -2.12 |
| ROCE % | 11.52% | 10.88% | 10.62% | 10.70% | 9.97% | 10.73% | 9.92% | 11.82% | 12.61% | 20.35% | 10.16% | 9.56% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Diluted EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Cash EPS (Rs.) | 10.00 | 10.12 | 19.28 | 7.75 | 5.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 44.86 | 40.43 | 38.03 | 27.54 | 24.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 44.86 | 41.50 | 39.10 | 28.61 | 25.32 |
| Revenue From Operations / Share (Rs.) | 554.84 | 390.97 | 412.12 | 310.20 | 193.80 |
| PBDIT / Share (Rs.) | 21.39 | 20.96 | 31.64 | 17.29 | 14.57 |
| PBIT / Share (Rs.) | 14.75 | 13.24 | 22.85 | 12.82 | 12.15 |
| PBT / Share (Rs.) | 5.28 | 3.48 | 14.62 | 4.84 | 4.17 |
| Net Profit / Share (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| PBDIT Margin (%) | 3.85 | 5.36 | 7.67 | 5.57 | 7.51 |
| PBIT Margin (%) | 2.65 | 3.38 | 5.54 | 4.13 | 6.26 |
| PBT Margin (%) | 0.95 | 0.88 | 3.54 | 1.56 | 2.15 |
| Net Profit Margin (%) | 0.60 | 0.61 | 2.54 | 1.05 | 1.59 |
| Return on Networth / Equity (%) | 7.48 | 5.93 | 27.59 | 11.92 | 12.76 |
| Return on Capital Employeed (%) | 15.20 | 16.84 | 35.07 | 24.49 | 21.89 |
| Return On Assets (%) | 1.19 | 0.95 | 6.00 | 1.91 | 2.17 |
| Long Term Debt / Equity (X) | 1.07 | 0.82 | 0.59 | 0.73 | 1.12 |
| Total Debt / Equity (X) | 2.69 | 2.47 | 2.10 | 2.75 | 3.36 |
| Asset Turnover Ratio (%) | 2.08 | 1.83 | 2.38 | 1.98 | 1.48 |
| Current Ratio (X) | 1.02 | 1.05 | 0.98 | 1.07 | 1.17 |
| Quick Ratio (X) | 0.67 | 0.65 | 0.45 | 0.52 | 0.40 |
| Inventory Turnover Ratio (X) | 6.56 | 4.65 | 4.37 | 3.22 | 2.10 |
| Interest Coverage Ratio (X) | 2.26 | 2.15 | 3.85 | 2.17 | 1.83 |
| Interest Coverage Ratio (Post Tax) (X) | 1.35 | 1.25 | 2.28 | 1.41 | 1.39 |
| Enterprise Value (Cr.) | 28.04 | 25.00 | 48.28 | 10.15 | 10.42 |
| EV / Net Operating Revenue (X) | 0.56 | 0.71 | 1.30 | 0.36 | 0.59 |
| EV / EBITDA (X) | 14.56 | 13.25 | 16.96 | 6.52 | 7.95 |
| MarketCap / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| Price / BV (X) | 4.43 | 4.58 | 12.15 | 1.52 | 1.59 |
| Price / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.07 | 0.08 |
After reviewing the key financial ratios for Advance Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has decreased from 10.12 (Mar 24) to 10.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 40.43 (Mar 24) to 44.86, marking an increase of 4.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 41.50 (Mar 24) to 44.86, marking an increase of 3.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.84. It has increased from 390.97 (Mar 24) to 554.84, marking an increase of 163.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.39. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 21.39, marking an increase of 0.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.75. This value is within the healthy range. It has increased from 13.24 (Mar 24) to 14.75, marking an increase of 1.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 5.28, marking an increase of 1.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For PBDIT Margin (%), as of Mar 25, the value is 3.85. This value is below the healthy minimum of 10. It has decreased from 5.36 (Mar 24) to 3.85, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has decreased from 3.38 (Mar 24) to 2.65, marking a decrease of 0.73.
- For PBT Margin (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 10. It has increased from 0.88 (Mar 24) to 0.95, marking an increase of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.48. This value is below the healthy minimum of 15. It has increased from 5.93 (Mar 24) to 7.48, marking an increase of 1.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.20. This value is within the healthy range. It has decreased from 16.84 (Mar 24) to 15.20, marking a decrease of 1.64.
- For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 1.19, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has increased from 0.82 (Mar 24) to 1.07, marking an increase of 0.25.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.69. This value exceeds the healthy maximum of 1. It has increased from 2.47 (Mar 24) to 2.69, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 1.5. It has decreased from 1.05 (Mar 24) to 1.02, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.67, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.56. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 6.56, marking an increase of 1.91.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.15 (Mar 24) to 2.26, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 1.25 (Mar 24) to 1.35, marking an increase of 0.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.04. It has increased from 25.00 (Mar 24) to 28.04, marking an increase of 3.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.56, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 14.56. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 14.56, marking an increase of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 4.43. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 24) to 4.43, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Advance Petrochemicals Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.2% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.48% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 472 (Industry average Stock P/E: 171.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.69
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%
Fundamental Analysis of Advance Petrochemicals Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | 36, Kothari Market, Kankaria Road, Ahmedabad Gujarat 380022 | info@advancepetro.com http://www.advancepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pulkit Goenka | Chairman & Managing Director |
| Ms. Aanchal Arvind Goenka | Director |
| Mr. Akshat Shukla | Director |
| Mr. Arvind Vishwanath Goenka | Director |
| Mr. Nirish Jagabhai Parikh | Director |
| Mrs. Palak Tapas Relia | Director |
Advance Petrochemicals Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹168.80 |
| Previous Day | ₹177.65 |
FAQ
What is the intrinsic value of Advance Petrochemicals Ltd?
Advance Petrochemicals Ltd's intrinsic value (as of 10 December 2025) is 1256.11 which is 498.15% higher the current market price of 210.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 18.9 Cr. market cap, FY2025-2026 high/low of 263/169, reserves of ₹2.91 Cr, and liabilities of 22.87 Cr.
What is the Market Cap of Advance Petrochemicals Ltd?
The Market Cap of Advance Petrochemicals Ltd is 18.9 Cr..
What is the current Stock Price of Advance Petrochemicals Ltd as on 10 December 2025?
The current stock price of Advance Petrochemicals Ltd as on 10 December 2025 is 210.
What is the High / Low of Advance Petrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Advance Petrochemicals Ltd stocks is 263/169.
What is the Stock P/E of Advance Petrochemicals Ltd?
The Stock P/E of Advance Petrochemicals Ltd is 472.
What is the Book Value of Advance Petrochemicals Ltd?
The Book Value of Advance Petrochemicals Ltd is 42.3.
What is the Dividend Yield of Advance Petrochemicals Ltd?
The Dividend Yield of Advance Petrochemicals Ltd is 0.00 %.
What is the ROCE of Advance Petrochemicals Ltd?
The ROCE of Advance Petrochemicals Ltd is 9.56 %.
What is the ROE of Advance Petrochemicals Ltd?
The ROE of Advance Petrochemicals Ltd is 7.71 %.
What is the Face Value of Advance Petrochemicals Ltd?
The Face Value of Advance Petrochemicals Ltd is 10.0.